Cargando…
Development and validation of a combined metabolism and immune prognostic model in lung adenocarcinoma
BACKGROUND: Tumor metabolism and immune response can affect the biological behavior of tumor cells. There is an obvious relationship between glycolysis and immune response. However, the association between metabolism and immune response and prognosis in lung adenocarcinoma (LUAD) has not yet been ex...
Autores principales: | Shi, Yu, Dai, Shihui, Lei, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840026/ https://www.ncbi.nlm.nih.gov/pubmed/36647508 http://dx.doi.org/10.21037/jtd-22-1695 |
Ejemplares similares
-
Development and validation of a combined ferroptosis and immune prognostic signature for lung adenocarcinoma
por: Li, Han, et al.
Publicado: (2022) -
Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Lung Adenocarcinoma
por: Huang, Hua, et al.
Publicado: (2022) -
Systematic construction and validation of an immune prognostic model for lung adenocarcinoma
por: Luo, Chenghan, et al.
Publicado: (2019) -
Development and validation of prognostic models for colon adenocarcinoma based on combined immune-and metabolism-related genes
por: Jiang, Hui-zhong, et al.
Publicado: (2022) -
Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)